Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
09.01. | Tenon Medical, Inc.: Tenon Medical to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco | 187 | ACCESS Newswire | LOS GATOS, CA / ACCESSWIRE / January 9, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders... ► Artikel lesen | |
13.11.24 | Tenon Medical GAAP EPS of -$3.63, revenue of $0.88M misses by $0.38M | 3 | Seeking Alpha | ||
13.11.24 | Tenon Medical, Inc.: Tenon Medical Reports Third Quarter 2024 Financial Results | 479 | ACCESS Newswire | ~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~~ Published Interim Analysis from MAINSAIL Study; Post-Market... ► Artikel lesen | |
12.11.24 | Earnings Preview For Tenon Medical | 3 | Benzinga.com | ||
TENON MEDICAL Aktie jetzt für 0€ handeln | |||||
04.11.24 | Tenon Medical, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
30.10.24 | Tenon Medical, Inc.: Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran SE SI Joint Fusion System | 285 | ACCESS Newswire | ~ Procedures Completed in Various Spine & Pain Centers of Excellence Throughout the Country Including in Idaho, Pennsylvania, Minnesota, Arizona and Utah ~~Feedback From Initial Physician Users to Support... ► Artikel lesen | |
30.10.24 | Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results | 187 | ACCESS Newswire | LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders... ► Artikel lesen | |
28.10.24 | Tenon Medical regains compliance with Nasdaq | 1 | Seeking Alpha | ||
28.10.24 | Tenon Medical, Inc.: Tenon Medical Regains Full Compliance with Nasdaq Continued Listing Requirements | 176 | ACCESS Newswire | LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders... ► Artikel lesen | |
17.10.24 | Tenon Medical files to sell 2.4M shares of common stock for holders | 8 | Seeking Alpha | ||
17.10.24 | Tenon Medical, Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
17.10.24 | Tenon Medical secures three new US patents | 8 | Investing.com | ||
17.10.24 | Tenon Medical, Inc.: Tenon Medical Announces Issuance of Three U.S. Patents | 269 | ACCESS Newswire | Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17, 2024 /... ► Artikel lesen | |
20.09.24 | Why Tenon Medical (TNON) Stock Is Skyrocketing Friday | 7 | Benzinga.com | ||
19.09.24 | Tenon Medical sichert sich drei neue US-Patentgenehmigungen | 14 | Investing.com Deutsch | ||
19.09.24 | Tenon Medical secures three new US patent allowances | 2 | Investing.com | ||
19.09.24 | Tenon Medical, Inc.: Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO | 457 | ACCESS Newswire | Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON)... ► Artikel lesen | |
17.09.24 | Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules | 377 | ACCESS Newswire | LOS GATOS, CA / ACCESSWIRE / September 17, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint)... ► Artikel lesen | |
16.09.24 | Tenon Medical, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
13.09.24 | Tenon Medical (TNON) Stock Is Up 180%: What's Going On? | 9 | Benzinga.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 89,43 | -0,59 % | Medtronic Launches Bold 10-Year Global Initiative To Propel 1M Low-Income Students Into Health Tech Careers | Medtronic Spark will provide young people from low-income households the skills needed for well-paying jobs in a growing industry facing a global workforce shortage CLAREGALWAY, IE / ACCESS Newswire... ► Artikel lesen | |
NUGEN MEDICAL DEVICES | 0,044 | +6,80 % | Unglaubliche News! Der Super-CEO der alle Türen öffnen kann! | ||
VERU | 0,472 | -1,99 % | Veru Inc.: Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress | --Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 0,770 | +2,67 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
TENET | 121,00 | +1,68 % | Tenet Healthcare's Cheaper Valuation: A Hidden Gem in Healthcare? | ||
SOMNIGROUP INTERNATIONAL | 60,50 | 0,00 % | Somnigroup International files to sell 34.2M shares of common stock for holders | ||
SINTX TECHNOLOGIES | 2,980 | 0,00 % | Why SINTX Technologies Stock Is Down 21% | ||
INTELLIGENT BIO SOLUTIONS | 1,475 | -100,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy | NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
VIVOS THERAPEUTICS | 3,320 | 0,00 % | Cellev8 Nutrition Inc: Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress | WELLINGTON, FL and HIGHLANDS RANCH, CO / ACCESSWIRE / December 10, 2024 / Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed... ► Artikel lesen | |
NAYA BIOSCIENCES | 0,370 | +4,23 % | NAYA Biosciences, Inc.: NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment | SARASOTA, Fla. and MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients... ► Artikel lesen | |
LUMIRADX | - | - | LumiraDx Ltd - 6-K, Report of foreign issuer | ||
FRESENIUS | 39,230 | +2,00 % | Sparprogramm von Fresenius zahlt sich aus - Überraschend gutes Schlussquartal | BAD HOMBURG (dpa-AFX) - Beim Fresenius-Konzern haben sich im vergangenen Jahr der Umbau und das Sparprogramm ausgezahlt. Zudem profitierte der Dax-Konzern von guten Geschäften der Generikatochter Kabi... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 54,04 | +0,52 % | EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Kauf von Siemens Healthineers Aktien für einen Betrag von EUR 6.767,73 abzüglich Steuern und Abgaben als automatische Wiederanlage von ... | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
25.02.2025 / 16:23... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 47,460 | +2,28 % | DAX schwächer erwartet: Rheinmetall, FMC und Heidelberg Materials im Fokus | Dem Erholungsversuch des DAX geht am Dienstag bereits wieder etwas die Luft aus. Der Broker IG taxierte den deutschen Leitindex rund drei Stunden vor dem Handelsstart knapp 0,3 Prozent tiefer auf 22.361... ► Artikel lesen | |
PROGYNY | 22,000 | 0,00 % | Progyny, Inc. Announces Fourth Quarter 2024 Results | Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025, Reflecting Tenth Consecutive Year of... ► Artikel lesen |